Skip to Main Content Health Care Professionals Haldimand-Norfolk Health Unit Search

Eligibility and Recommendations for Staying Up To Date with your COVID-19 Vaccine

 

 

Children Aged 6 Months to 5 Years Old

Children aged 6 months to 5 years old are eligible to receive a primary COVID-19 vaccine series (i.e. two doses of pediatric Moderna) to be up to date with their COVID-19 vaccines.

Booster doses of COVID-19 vaccine are not currently recommended for this age group.

Individuals must be at least 6 months of age on or before the date of their appointment to be eligible.

If someone other than a parent/legal guardian will be bringing a child for their COVID-19 vaccine (e.g. grandparent, uncle, older sibling, etc.) a parent/legal guardian MUST complete this COVID-19 Vaccine Children/Youth (Age 5-17) Consent Form and send a signed copy with the child to the clinic. If you are unable to print a copy of the consent form please call 519-427-5903.

 

Children Aged 5 to 11 Years Old

Children aged 5 to 11 years old are recommended/eligible to receive a primary COVID-19 vaccine series (i.e. two doses of pediatric Pfizer) followed by a booster dose to be up to date with their COVID-19 vaccines.

The booster dose is recommended ≥6 months after the last dose of their primary COVID-19 vaccine series.

Individuals must have already had their 5th birthday on or before the date of their appointment to be eligible for a booster.

If someone other than a parent/legal guardian will be bringing a child for their COVID-19 vaccine (e.g. grandparent, uncle, older sibling, etc.) a parent/legal guardian MUST complete this COVID-19 Vaccine Children/Youth (Age 5-17) Consent Form and send a signed copy with the child to the clinic. If you are unable to print a copy of the consent form please call 519-427-5903.

 

People Aged 12-17 Years Old

People aged 12-17 years old are recommended/eligible to receive a primary COVID-19 vaccine series (e.g. two doses of Pfizer or Moderna), followed by a booster dose to be up to date with their COVID-19 vaccines.

The booster dose is recommended ≥6 months after the last dose of their primary COVID-19 vaccine series.

 

People Aged 18 Years and Older 

People aged 18 and older are eligible to receive a primary COVID-19 vaccine series (e.g. two doses of Pfizer or Moderna), followed by two booster doses to be up to date with their COVID-19 vaccines.

It is recommended that COVID-19 booster doses be administered at an interval of 6 months (168 days) after a previous COVID-19 vaccine.

 

Residents of Long-Term Care Homes, Retirement Homes, Elder Care Lodges and Older Adults Living in other Congregate Settings

Residents of Long-Term Care Homes, Retirement Homes, Elder Care Lodges and older adults living in other congregate settings are recommended/eligible to receive a primary COVID-19 vaccine series (e.g. two doses of Pfizer or Moderna), followed by two booster doses to be up to date with their COVID-19 vaccines.

It is recommended that COVID-19 booster doses be administered at an interval of 6 months (168 days) after a previous COVID-19 vaccine.

 

People who are Moderately or Severely Immunocompromised 

Moderately or severely immunocompromised people aged 5 and older are recommended/eligible to receive a 3-dose primary COVID-19 vaccine series.

After completion of a 3-dose primary series, moderately or severely immunocompromised people should follow the relevant first and second (if eligible) booster dose recommendations, based on age, to be up to date with their COVID-19 vaccines.

Eligible high-risk health conditions for a 3-dose primary series are listed below. Proof of condition is required at clinic – i.e. detailed referral note from physician/specialist or current prescription.

 

  • Transplant recipients (including solid organ transplant and hematopoietic stem cell transplants)
  • Patients with hematological cancers (examples include lymphoma, myeloma, leukemia) on active treatment (chemotherapy, targeted therapies, immunotherapy)
  • Recipients of an anti-CD20 agent (e.g. rituximab, ocrelizumab, ofatumumab)
  • Those undergoing active treatment for solid tumors
  • Those who are in receipt of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
  • Those receiving dialysis (hemodialysis or peritoneal dialysis)
  • Those with moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • Stage 3 or advanced untreated HIV infection and those with acquired immunodeficiency syndrome
  • Those undergoing active treatment with the following categories of immunosuppressive therapies: anti-B cell therapies (monoclonal antibodies targeting CD19, CD20 and CD22), high-dose systemic corticosteroids, alkylating agents, antimetabolites, or tumor-necrosis factor (TNF) inhibitors and other biologic agents that are significantly immunosuppressive.

A complete list of eligible immunosuppressive medications can be found in this Ministry document. Prescriptions or medication bottles for immunosuppressants listed in the table may be presented for a 3rd dose. If the immunosuppressive medication is not listed, a referral form/ letter from a health care provider is required.

 

First Nation, Inuit and Métis Adults

First Nation, Inuit and Métis individuals (and their non-Indigenous household members) who are 18 years of age and older are recommended to receive a primary COVID-19 vaccine series (e.g. two doses of Pfizer or Moderna, or three doses if moderately or severely immunocompromised), followed by two booster doses to be up to date with their COVID-19 vaccines.

It is recommended that COVID-19 booster doses be administered at an interval of 6 months (168 days) after a previous COVID-19 vaccine.

 

People Who Received Vaccines Not Authorized by Health Canada

People who received only one or two doses of a non-Health Canada (HC) authorized COVID-19 vaccine may receive one additional dose in Ontario at least 28 days after the previous dose to complete the primary series.

People who received one HC authorized vaccine and one non-HC authorized vaccine (in either order) need no additional doses to complete the primary series.

People who received three doses (any combination of HC authorized, and nonHC authorized) need no additional doses to complete the primary series.

Following any additional doses needed to complete the primary series, these individuals should follow the relevant age-based booster dose recommendations, as outlined on page 2, to be up to date with their COVID-19 vaccines.

 

People Who Have Had a COVID-19 Infection

People who have had a COVID-19 infection should receive the recommended number of doses as outlined above. However, they are recommended to wait 4 to 8 weeks after having a COVID-19 infection to get the next dose in their primary series (e.g. between first and second doses of Pfizer or Moderna).

People who get COVID-19 after a completed primary series are recommended to wait 3 months after having COVID-19 before receiving either their first or second booster dose.

Optimal timing can be discussed with a health care provider and depends on age, number of doses received, risk of exposure and health status.

 

Eligibility will be checked at the clinic and ineligible individuals will be turned away.